Given the healthy earnings growth (21% EPS CAGR over FY17-19E), asset-light business model (core RoCE of ~70% in FY16), and FCF generation of Rs 14-15bn in FY18-19, high valuations are natural. We re-initiate coverage with a BUY and TP of Rs 3,773 based on 35x Mar-19 EPS.